1. Vallera DA: Immunotoxins: Will their clinical promise be fulfilled? Blood 83:309?317, 1994
2. Frankel A: Immunotoxin therapy of cancer. Oncology 7(5):69?98, 1993
3. Grossbard ML, O'Day S, Gribben JG, Freedman AS, Rabinowe SN, Newbey D, Esseltine DL, Epstein CL, Nadler LM: Anti-B4-blocked ricin therapy following autologous bone marrow transplantation for B-cell non-Hodgkin's lymphoma: Update of Phase I/II trials. Blood 82:444a, 1993
4. LeMaistre CF, Meneghetti C, Rosenblum M, et al: Phase I trial of an IL-2 fusion toxin in hematologic malignancies. Blood 79:2547?2554, 1992
5. LeMaistre CF, Craig FE, Meneghetti C, et al: Phase I trial of a 90 minute infusion of the fusion toxin DAB 486 IL-2 in hematologic cancers. Cancer Res 53:3930?3934, 1993